Filing Details
- Accession Number:
- 0001104659-24-082630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-25 16:05:09
- Reporting Period:
- 2024-07-23
- Accepted Time:
- 2024-07-25 16:05:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1400118 | Sagimet Biosciences Inc. | SGMT | Pharmaceutical Preparations (2834) | 205991472 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1858176 | George Kemble | Sagimet Biosciences Inc. 155 Bovet Rd., Suite 303 San Mateo CA 94402 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Common Stock | Disposition | 2024-07-23 | 23,625 | $3.17 | 118,693 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.07 to $3.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
